Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact
Go back to Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact| PANDORA MEDIA, Inc. (NYSE: P) | Delayed: 98.15 +5.72 (6.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.43 | 52 Week High | $16.23 | |||
| Open | $91.78 | 52 Week Low | $7.10 | |||
| Day High | $98.26 | P/E | N/A | |||
| Day Low | $91.36 | EPS | $-0.15 | |||
| Volume | 2,668,156 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.81 -0.21 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.02 | 52 Week High | $37.39 | |||
| Open | $29.09 | 52 Week Low | $28.25 | |||
| Day High | $29.21 | P/E | 17.46 | |||
| Day Low | $28.44 | EPS | $1.65 | |||
| Volume | 26,721,664 | |||||
